Enfortumab Vedotin and Pembrolizumab - A New Perspective on Urothelial Cancer. Niegisch G. N Engl J Med 2024;390:944-946.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Niegisch G. Enfortumab Vedotin and Pembrolizumab - A New Perspective on Urothelial Cancer. N Engl J Med 2024;390:944-946.
PMID: 38446680